Experience

Sardona Therapeutics

• United States
• Biotechnology Research
• 1 - 100 Employee

• Co-Founder, CEO, President

  • Jan 2021 - 3 years

  San Francisco Bay Area Sardona Therapeutics is a precision oncology company that is developing a portfolio of small molecules targeting RNA-binding proteins (RBPs) for the treatment of cancer. By targeting RBPs, Sardona’s small molecules are designed to inhibit downstream dysregulated RNA that are causative of tumor growth resulting in a differentiated approach to tackle clinically-validated oncogenic drivers for the treatment of cancer.


David Geffen School of Medicine at UCLA
• United States
• Higher Education
• 700 & Above Employee
• Assistant Professor Hematology/Oncology

  • Feb 2019 - Jan 2021


University of California, Los Angeles

• Information Services
• 1 - 100 Employee

• Scientist, Hematology/Oncology

  • Feb 2017 - Dec 2019

  David Geffen School of Medicine at UCLA

• Postdoctoral Fellow, Biochemistry

  • Jun 2015 - Feb 2017

  Greater Los Angeles Area



Roche

• Switzerland
• Biotechnology Research
• 700 & Above Employee

• Research Associate

  • Feb 2008 - Jul 2008

  Basel Area, Switzerland